Clearance of recalcitrant warts in a pediatric patient following administration of the nine-valent human papillomavirus vaccine

被引：9
|
作者：
Kost, Yana [1 ]
Zhu, Tian Hao [1 ]
Blasiak, Rachel C. [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
PEDIATRIC DERMATOLOGY | 2020年 / 37卷 / 04期
关键词：
infection-viral; warts; HPV;
D O I：
10.1111/pde.14150
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Verruca vulgaris is a common, benign infection of the skin and mucous membranes caused by human papillomavirus (HPV). Although many therapeutic options for warts exist, they have limited efficacy and there is no definitive cure for warts. We report the case of a 10-year-old girl with recalcitrant cutaneous warts persisting more than two years which resolved completely following vaccination with the nine-valent HPV vaccine.
引用
收藏
页码：748 / 749
页数：2
相关论文
共 50 条
  • [31] Efficacy of intralesional acyclovir versus quadrivalent human papillomavirus vaccine for treatment of recalcitrant cutaneous warts: a clinical trial
    Elyamany, Mona Ibrahim
    Obaid, Zakaria Mahran
    Fouda, Ibrahim
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [32] A case of lipoatrophy following quadrivalent human papillomavirus vaccine administration
    Stephan, Farid
    Korkomaz, Joelle
    Abadjian, Gerard
    Okais, Jad
    Tomb, Roland
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (06) : E132 - E134
  • [33] Post-marketing surveillance of human papillomavirus (HPV)-related high-grade cervical disease in a cohort of Chinese women who received the nine-valent HPV vaccine
    Yang, Yu
    Zhang, Liang
    Zhao, Houyu
    Meng, Ruogu
    Liu, Zhike
    Liu, Zuoxiang
    Ding, Keqin
    Zhan, Siyan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 150 - 151
  • [34] Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial
    Nofal, Ahmad
    Nofal, Hagar
    Alwirshiffani, Esam
    Elghareeb, Mohamed, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (05) : 1051 - 1052
  • [35] THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF SCHOOL-BASED NINE-VALENT HUMAN PAPILLOMAVIRUS FEMALE VACCINATION COMPARED WITH BI-VALENT AND QUADRIVALENT VACCINATION IN MALAYSIA
    Woo, Y.
    Hsu, T.
    Pavelyev, A.
    LeVan, R.
    Prabhu, V. S.
    VALUE IN HEALTH, 2018, 21 : S7 - S7
  • [36] Three cases of recalcitrant cutaneous warts treated with quadrivalent human papillomavirus (HPV) vaccine: the HPV type may not determine the outcome
    Hayashi, A.
    Matsumoto, K.
    Mitsuishi, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (05) : 1285 - 1287
  • [37] Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
    Olsson, Sven-Eric
    Restrepo, Jaime Alberto
    Reina, Julio Cesar
    Pitisuttithum, Punnee
    Ulied, Angels
    Varman, Meera
    Van Damme, Pierre
    Duarte Moreira, Edson, Jr.
    Ferris, Daron
    Block, Stanley
    Bautista, Oliver
    Gallagher, Nancy
    McCauley, Jennifer
    Luxembourg, Alain
    PAPILLOMAVIRUS RESEARCH, 2020, 10
  • [38] Regression of Cutaneous Warts in a Patient With WILD Syndrome Following Recombinant Quadrivalent Human Papillomavirus Vaccination
    Kreuter, Alexander
    Waterboer, Tim
    Wieland, Ulrike
    ARCHIVES OF DERMATOLOGY, 2010, 146 (10) : 1196 - 1197
  • [39] Identification of the skin virome in a boy with widespread human papillomavirus-2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine
    Landini, M. M.
    Borgogna, C.
    Peretti, A.
    Doorbar, J. .
    Griffin, H.
    Mignone, F.
    Lai, A.
    Urbinati, L.
    Matteelli, A.
    Gariglio, M.
    De Andrea, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (02) : 597 - 600
  • [40] Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study
    Joura, Elmar A.
    Ulied, Angels
    Vandermeulen, Corinne
    Rua Figueroa, Milagrosa
    Seppa, Ilkka
    Hernandez Aguado, Juan Jose
    Ahonen, Anitta
    Reich, Olaf
    Virta, Miia
    Perino, Antonino
    Peris Tuser, Merce
    Peters, Klaus
    Origoni, Massimo
    Raspagliesi, Francesco
    Tjalma, Wiebren A. A.
    Tummers, Philippe
    Woelber, Linn
    Nieminen, Pekka
    van Damme, Pierre
    Sehouli, Jalid
    Fiol Ruiz, Gabriel
    Brucker, Sara
    Fehm, Tanja
    Cheon, Kyeongmi
    Rawat, Sonali
    Luxembourg, Alain
    Wittke, Frederick
    VACCINE, 2021, 39 (20) : 2800 - 2809
12345